Top Markets
Coin of the day
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Rank in Stocks #33504
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Share Price
$1.12
Last synced: 2026-08-14
Market Cap
$7.52M
Change (1 day)
4.51%
Change (1 year)
-94.79%
Country
US
Trade NeoImmuneTech, Inc. (950220)

Category

Dividend yield history for NeoImmuneTech, Inc. (950220)
NeoImmuneTech, Inc. (stock symbol: 950220) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for NeoImmuneTech, Inc. (950220) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors